Johnson & Johnson trades above 21x forward EPS with $24B in Q3 revenue, and a raised FY25 sales guidance outlook. Read why JNJ stock is downgraded to hold.

Nvidia and Eli Lilly unveiled a co-innovation AI Lab for drug discovery efforts. Nvidia announced a strategic collaboration ...

Investing.com - Futures linked to Canada’s main stock exchange pointed higher on Friday, as investors eyed a slight recovery ...

ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...

AbbVie continues to project low single-digit growth through 2030 as it expands its immunology franchise and makes a major ...

Businesses of all sizes are wasting little time jumping into the world of artificial intelligence and using the technology as ...

JTA's proposed fare hikes for Connexion Plus, a service for disabled riders, are facing backlash over affordability concerns.

Dow, S&P 500, and Nasdaq futures are rising in premarket trading as the stock market reacts to renewed AI hope and easing fears about Trump initiating military action in Iran.

Trump speech at Davos, Martin Luther King Jr. holiday, PCE inflation report, GDP update, and earnings from Netflix, Intel, ...

The S&P 500 finished lower on Friday, but smaller stocks wrapped up a stellar week. The market benchmark dipped about 0.1%. The Dow Jones Industrial Average dropped 87 points, or 0.2%. The Nasdaq ...

Johnson & Johnson (JNJ) closed the most recent trading day at $209.72, moving +2.61% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.16%. On the other hand, the Dow ...

Bank earnings start today, and consumer inflation data are due. Follow along for live updates on markets and the top finance, ...